Swissmedic

Summary report on authorisation – Enflonsia®

Marketing authorisation granted for Enflonsia®.

Low obligation Product class Pharmaceuticals Switzerland Pharmaceuticals

10.07.2026

Dates and deadlines

Regulatory Deadline

October 07, 2026

Read the official source ↗

Published by Swissmedic. HealthSignal links to the original document; the summary above is extracted from the source text.